Estimation of the target population of a selective cardiac myosin inhibitor for hypertrophic obstructive cardiomyopathy: Real-life data from the French REMY register.
European Hospital Georges Pompidou, Paris (France)
0
follower
6
more
presentations
in this session
Patient-reported outcome measures in wild-type and variant cardiac transthyretin amyloidosis: the ITALY (impact of transthyretin amyloidosis on life quality) study
A novel myocardium functional echocardiographic parameter, left ventricular myocardial work, associates with sudden cardiac risk score in patients with hypertrophic cardiomyopathy